BNP Paribas Asset Management’s Prothena Corp PRTA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-683
Closed -$4K 2031
2025
Q2
$4K Buy
+683
New +$5.13K ﹤0.01% 2075
2016
Q1
Sell
-120,667
Closed -$8.22M 1080
2015
Q4
$8.22M Buy
120,667
+13,948
+13% +$841K 0.07% 344
2015
Q3
$4.84M Buy
+106,719
New +$6.22M 0.04% 479

Other funds holding PRTA

BNP Paribas Asset Management's PRTA Position: Q3 2025 in Review

BNP Paribas Asset Management sold out of Prothena Corp (PRTA) in Q3 2025, closing a stake of 683 shares — an estimated $4K sold.

BNP Paribas Asset Management first reported a position in PRTA in Q3 2015 and held it in 3 quarters. The position peaked at $8.22M in Q4 2015. 187 funds tracked by Wall St. Rank hold PRTA as of Q3 2025.

  • BNP Paribas Asset Management reported no remaining Prothena Corp position as of Q3 2025 after selling out during the quarter.
  • BNP Paribas Asset Management sold 683 Prothena Corp shares in Q3 2025, an estimated $4K.
  • BNP Paribas Asset Management first reported a position in Prothena Corp in Q3 2015 and held it in 3 quarters.
  • BNP Paribas Asset Management's Prothena Corp position peaked at $8.22M in Q4 2015.
  • 187 funds tracked by Wall St. Rank held Prothena Corp as of Q3 2025.

Based on BNP Paribas Asset Management's 13F filing for Q3 2025, filed 7 Nov 2025.